ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 677411 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 677411; 2) Community: the network communities that were significantly associated with the response to NSC 677411; 3) Molecule: the relationships between components within communities and NSC 677411; 4) MDR: the compounds that were significantly associated with the NSC 677411.

NSC Compound Enrichment Correlation
NSC 752385 Null 0.00593538156800951 0.10975629
NSC 753575 N1-(1,3-benzothiazol-2-yl)-2-{2-methoxy-5-[(E)-3-oxo-3-(3,4,5-trimethoxyphenyl)-1-propenyl]phenoxy}acetamide 0.00593538156800951 0.1064266
NSC 106557 5.alpha.,25D-Spirostan-3.beta.-ol glycoside 0.00617256681787881 0.15245857
NSC 606699 Rapamycin prodrug, Mono-(28)-N,N-diethylpropionate-, hydrochloride salt 0.00617256681787881 0.25948369
NSC 635306 Null 0.00617256681787881 0.17768407
NSC 671033 Null 0.00617256681787881 0.18723964
NSC 678106 Rhamnazin 0.00617256681787881 0.4226896
NSC 701022 Null 0.00617256681787881 0.13150071
NSC 709358 1H-Pyrrole-2-carboxamide, N-[3-(dimethylamino)propyl]-1-methyl-4-[[[1-methyl- 4-[[1-oxo-4-[[(2,3,5,11a-tetrahydro-7-methoxy-5-oxo- 1H-pyrrolo[2,1-c][1,4]benzodiazepin-8-yl]oxy]butyl]amino]- 1H-pyrrol 0.00617256681787881 0.16200634
NSC 710326 Null 0.00617256681787881 0.037736209
Total:46  Current:8    [First] [Prev] [Next] [Last]